In the Bezafibrate Infarction Prevention (BIP) study an overall trend of a 9.4% reduction of the incidence of primary end point (fatal or nonfatal myocardial infarction or sudden death) was observed.
← all excerpts
"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
1
—
—